XML 96 R113.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Information - Reportable Segment Information (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Segment Reporting Information [Line Items]      
Net sales $ 5,140,084 $ 3,977,539 $ 3,398,719
Segment assets 13,287,411 12,889,395  
Operating profit 665,270 583,882 552,630
Legal Charges/Credits, net 0 0 56,000
Restructuring and Other Charges, net (29,765) (5,079) (19,711)
Gain on Sale of Assets (2,367) 1,177 184
Interest expense (138,221) (132,558) (65,363)
Loss on extinguishment of debt 0 (38,810) 0
Other income (expense), net 30,403 35,243 49,778
Income before taxes 557,452 447,757 537,045
Corporate and Other [Member]      
Segment Reporting Information [Line Items]      
Operational Improvement Initiatives (2,267) (2,169) (1,802)
Acquisition Related Costs 0 1,289 (20,389)
Integration Related Costs (55,160) (7,188) (4,179)
Legal Charges/Credits, net 0 0 (1,000)
Tax assessment 0 0 (5,331)
Restructuring and Other Charges, net (29,765) (4,086) (19,711)
Gain on Sale of Assets (2,367) 1,177 184
FDA Mandated Product Recall 11,314 0 0
UK Pension Settlement Charges $ (5,940) $ (89,632) $ 0
Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Profit margin 12.90% 14.70% 16.30%
Operating Segments [Member] | Flavors [Member]      
Segment Reporting Information [Line Items]      
Net sales $ 3,200,520 $ 2,091,635 $ 1,632,166
Segment assets 10,319,779 9,677,139  
Operating profit $ 482,394 $ 419,264 $ 358,266
Profit margin 15.10% 20.00% 22.00%
Operating Segments [Member] | Fragrances [Member]      
Segment Reporting Information [Line Items]      
Net sales $ 1,939,564 $ 1,885,904 $ 1,766,553
Segment assets 2,757,491 2,649,103  
Operating profit $ 349,445 $ 325,901 $ 314,899
Profit margin 18.00% 17.30% 17.80%
Global [Member]      
Segment Reporting Information [Line Items]      
Segment assets $ 210,141 $ 563,153  
Operating profit (38,759) (67,799) $ (54,538)
Nutrition & Biosciences, Inc [Member]      
Segment Reporting Information [Line Items]      
Business Acquisition, Transaction Costs 75,000    
Nutrition & Biosciences, Inc [Member] | Corporate and Other [Member]      
Segment Reporting Information [Line Items]      
Acquisition Related Costs (20,747) 0 0
Frutarom Industries Ltd. [Member]      
Segment Reporting Information [Line Items]      
Amortization   23,500  
Business Acquisition, Transaction Costs   66,000  
Acquisition-related Costs [Member]      
Segment Reporting Information [Line Items]      
Operating profit (250) 7,125 (11,000)
UNITED KINGDOM | Corporate and Other [Member]      
Segment Reporting Information [Line Items]      
FDA Mandated Product Recall $ 0 $ 0 $ (2,769)